Novel transcript, antisense to SMAP2 (ENSG00000290111)

ENSG00000290111, designated as "novel transcript, antisense to SMAP2," is annotated as an RNA gene producing a transcript that is antisense to the SMAP2 locus[1]. It does not encode a protein or act as a receptor, enzyme, transporter, or other canonical drug target. Antisense transcripts can influence the expression, processing, or stability of their sense (protein-coding) gene counterparts through mechanisms such as RNA masking, chromatin modification, or modulation of transcriptional dynamics, but specific biological functions for this transcript have not been described in available scientific literature[3][4]. There are no known drugs, disease associations, or biomarker uses for this transcript. The entry is more accurately described as a non-coding RNA gene of uncertain function, not as a classical therapeutic target or receptor. The designation "novel transcript" further suggests incomplete annotation and a lack of experimental characterization[1].

Other names

antisense to SMAP2 RNAENSG00000290111